Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Women With Premature Ovarian Insufficiency
NCT07815509Phase 2Not yet recruiting
- Sponsor
- The University of Hong Kong-Shenzhen Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of finerenone in premature ovarian insufficiency (POI), sponsored by The University of Hong Kong-Shenzhen Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT07815509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07815509.